Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at a

The adolescent study was registered at ClinicalTrials.gov on 26 March 2009 (NCT00870350).